Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Aromatase Inhibitors : Types, Mode of Action and Indications, PDF eBook

Aromatase Inhibitors : Types, Mode of Action and Indications PDF

Edited by Jean R Lamonte

PDF

Please note: eBooks can only be purchased with a UK issued credit card and all our eBooks (ePub and PDF) are DRM protected.

Description

Aromatase inhibitors (AI) are a class of drugs used in the treatment of breast cancer and ovarian cancer in postmenopausal women.

Aromatase is an enzyme that synthesizes estrogen and aromatase inhibitors block the synthesis of estrogen, which is needed in some cancers to grow.

As breast tissue is stimulated by estrogens, decreasing their production is a way of suppressing recurrence of the breast tumor tissue.

In contrast to pre-menopausal women, in whom most of the estrogen is produced in the ovaries, in post-menopausal women most of the body's estrogen is produced in the adrenal gland from the conversion of androgens.

Investigations are ongoing to look for other applications and researchers continue to study aromatase inhibitors as a way to stimulate ovulation or suppress estrogen production in endometriosis.

This new book presents the latest research from around the world in this dynamic field.

Information

Information